Healthcare provider profile · identity verified

Sayed Amirhossein Khademi, MD

Internal Medicine · EVERETT, WA · NPI 1407271547

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	715	218
Losartan Potassium	Losartan Potassium	342	96
Amlodipine Besylate	Amlodipine Besylate	338	103
Lisinopril	Lisinopril	325	99
Levothyroxine Sodium	Levothyroxine Sodium	317	86
Metoprolol Succinate	Metoprolol Succinate	311	79
Rosuvastatin Calcium	Rosuvastatin Calcium	269	79
Tamsulosin Hcl	Tamsulosin Hcl	265	86
Gabapentin	Gabapentin	212	71
Metformin Hcl Er	Metformin Hcl	207	57
Sertraline Hcl	Sertraline Hcl	171	49
Omeprazole	Omeprazole	166	57
Metformin Hcl	Metformin Hcl	159	50
Albuterol Sulfate Hfa	Albuterol Sulfate	158	67
Hydrochlorothiazide	Hydrochlorothiazide	154	45
Trazodone Hcl	Trazodone Hcl	152	49
Famotidine	Famotidine	132	46
Duloxetine Hcl	Duloxetine Hcl	125	34
Metoprolol Tartrate	Metoprolol Tartrate	124	37
Finasteride	Finasteride	120	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	19
Pantoprazole Sodium	Pantoprazole Sodium	109	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	104	18
Simvastatin	Simvastatin	96	28
Mirtazapine	Mirtazapine	94	25
Meloxicam	Meloxicam	90	44
Ozempic	Semaglutide	90	16
Bupropion Xl	Bupropion Hcl	88	22
Jardiance	Empagliflozin	87	27
Fluticasone Propionate	Fluticasone Propionate	85	44
Alendronate Sodium	Alendronate Sodium	80	24
Clopidogrel	Clopidogrel Bisulfate	80	21
Tizanidine Hcl	Tizanidine Hcl	80	35
Allopurinol	Allopurinol	79	24
Ezetimibe	Ezetimibe	79	21
Oxycodone Hcl	Oxycodone Hcl	75	16
Torsemide	Torsemide	74	19
Eliquis	Apixaban	71	22
Furosemide	Furosemide	71	25
Glipizide Er	Glipizide	71	28
Venlafaxine Hcl Er	Venlafaxine Hcl	69	16
Potassium Chloride	Potassium Chloride	67	22
Buspirone Hcl	Buspirone Hcl	65	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	21
Tramadol Hcl	Tramadol Hcl	61	24
Pravastatin Sodium	Pravastatin Sodium	56	13
Baclofen	Baclofen	53	20
Quetiapine Fumarate	Quetiapine Fumarate	52	14
Atenolol	Atenolol	51	15
Carvedilol	Carvedilol	51	15
Pioglitazone Hcl	Pioglitazone Hcl	51	14
Escitalopram Oxalate	Escitalopram Oxalate	47	13
Lovastatin	Lovastatin	46	12
Pregabalin	Pregabalin	46	23
Glipizide	Glipizide	44	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	12
Montelukast Sodium	Montelukast Sodium	44	15
Triamcinolone Acetonide	Triamcinolone Acetonide	44	29
Zolpidem Tartrate	Zolpidem Tartrate	41	17
Hydroxyzine Hcl	Hydroxyzine Hcl	40	12
Prednisone	Prednisone	40	23
Diclofenac Sodium	Diclofenac Sodium	39	18
Enalapril Maleate	Enalapril Maleate	38	suppressed
Fenofibrate	Fenofibrate	38	12
Mounjaro	Tirzepatide	38	suppressed
Propranolol Hcl	Propranolol Hcl	38	14
Trulicity	Dulaglutide	38	suppressed
Donepezil Hcl	Donepezil Hcl	37	suppressed
Glimepiride	Glimepiride	37	11
Prazosin Hcl	Prazosin Hcl	35	suppressed
Spironolactone	Spironolactone	34	11
Dutasteride	Dutasteride	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Alprazolam	Alprazolam	30	12
Doxazosin Mesylate	Doxazosin Mesylate	30	11
Lamotrigine	Lamotrigine	30	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	20
Lansoprazole	Lansoprazole	27	suppressed
Celecoxib	Celecoxib	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	12
Spiriva Handihaler	Tiotropium Bromide	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Clonazepam	Clonazepam	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Ondansetron Odt	Ondansetron	24	12
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	12
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Risperidone	Risperidone	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Methylprednisolone	Methylprednisolone	20	19
Sucralfate	Sucralfate	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	13
Etodolac	Etodolac	18	suppressed
Febuxostat	Febuxostat	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Eszopiclone	Eszopiclone	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Indapamide	Indapamide	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Mupirocin	Mupirocin	14	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Azithromycin	Azithromycin	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Nitroglycerin	Nitroglycerin	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Primidone	Primidone	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Testosterone	Testosterone	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error